ACHV
NASDAQ · Biotechnology
Achieve Life Sciences Inc
$7.59
+0.34 (+4.69%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+320.2% upside
Low Target
$22.93
Average Target
$31.89
High Target
$41.27
Current Price
$7.59
Current
$7.59
$7.59
Target
$31.89
$31.89
$22.93
$31.89 avg
$41.27
Scenario Analysis
Bear Case
$22.93
202.1%
Low target
Base Case
$31.89
+320.2%
Avg target
Bull Case
$41.27
+443.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$7.34
3.5% from high
52-Week Low
$2.45
+209.8% from low
Target vs 52W High
$31.89
+334.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -0.5% |
| AMGN | Hold | 43 | 49% | $190.87 | -55.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +152.8% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -17.0% |
| REGN | Buy | 37 | 70% | $76.80 | -90.5% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -54.1% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -47.2% |
| BIIB | Buy | 43 | 67% | $91.45 | -57.0% |